The first step for the demonstration of the association between cancer and viruses is to detect the virus in the affected tissues. 12 The primary evidence of the possibility of EBV involvement in breast cancer was reported by Lobreque et al who observed EBV sequencing in 21% of breast cancer specimens. 13 However, in other studies, there were different results with the probability of correlation between 0 and 100%. [13] [14] [15] [16] [17] [18] EBV was identified in non-cancer breast controls in only 2 of 13 studies. 19 EBV can contribute to the development of breast cancers directly through several mechanisms such as activation of HER2/HER3 signaling cascades. HER2 and HER3 are 2 of the cellular oncogenes associated with breast cancer. 20 EBV has an indirect role in breast cancer development by interfering with the immune response to HPV-transformed cells via the expression viral BCRF1 gene. This collaboration between EBV and HPV may increase their oncogenic potential. 21 Not only the association of the EBV with breast cancer is important but also understanding of the cause of breast cancer for the early diagnosis, prevention, and treatment of breast cancer is necessary]. 22 The aim of this study was to investigate the relationship between Epstein-Barr virus and breast cancer in women with this cancer in Khuzestan province. PCR for Amplification of Beta-Actin and EBV To investigate the quality of DNA extracted from cancerous and healthy tissues, about 1 μL of DNA is deposited in a nanodrop, and the amount of DNA absorption was measured at 280 to 260 UV. Suitability of DNA for PCR was analyzed by amplifying the housekeeping beta-actin gene. A 161 base pair fragment of beta-actin gene was reproduced using PCR by following primers: 5′AGACGCAGGATGGCATGGG3′ and 5′GAGACCTTAAACACCCCAGCC3′. Then PCR was performed for detection EBV sequence in DNA extraction using two specific primers 5′TCTTGAGGATCCGCTAGGATA3′ and 5′ACCGTGGTTCTGGACTATCTGGAT3′. The PCR program consisted of initial denaturing at 95°C for 5 minutes, followed by 30 cycles, including 94°C for 45 seconds, annealing at 61°C and 55°C respectively, for beta actin and EBV gene, for 45 seconds and extension at 72°C for 45 seconds and a final extension 72°C for 10 minutes. The reaction volume was 20 μL containing 10 μL master mix, 20 ng DNA, 1 pmol primer, PCR products were separated on 1.5% agarose gel. No-template control, as a negative control, was included in all PCR.
Statistical Analysis
To perform the analysis, Cramer test and SPSS 16 software were used. Statistical significance was a P value of less than 0.05.
Ethical Considerations
All patients and healthy donors provided their written informed constantly to take part in this study, and the study was approved by the Ethics Committee of Lorestan University.
Results
Evaluation of Concentration and Purity of DNA DNA extraction of cancerous and healthy samples that measured by UV absorption was used for amplification of constitutive beta actin gene. Results indicated that DNA extraction from 39 of the tumor samples and 37 of the healthy samples had acceptable quality and the band with a size of 161 bp was observed ( Figure 1 ).
Then, DNA Extraction from tumor and healthy samples were subjected to amplify EBV-DNA by specific primers; healthy samples did not show the EBV gene present, two out of the 39 breast cancer cases (5.12%) were diagnostically positive for EBV ( Figure 2 ).
Statistical Analyses
According to statistical analysis, the correlation coefficient of Cramer calculated as 0.160, and the criterion value of the decision is greater than 0.05. Therefore, the assumption was accepted. There is no meaningful relationship between breast cancer and Epstein-Barr virus in patients with this cancer in Khuzestan province.
Discussion
Breast cancer is the second leading cause of cancer death among woman and almost one in eight women in the United States will be diagnosed with breast cancer in her lifetime. Many studies have been conducted to identify the risk factors for this cancer, But known risk factors for less than half of all cases are justifiable, and the known molecular mechanisms of breast cancer are very rare. 17, 23 The involvement of various viruses in human breast cancer has been widely studied, and very variable results have been reported, some evidence agrees or disagrees with this, so the issue is controversial. 12 A possible explanation for the controversial results in correlation between EBV virus and breast cancer may result in the geographical variation in the incidence of EBV infections, for example, the primary infection with this virus in developing countries, especially in the Asian regions usually happens in the first decade of life, while in the western countries and developed regions primary infection by EBV occurs mainly in adolescence or adulthood. 24, 25 Moreover, different methods that used different EBV derived proteins or nucleic acids targeted for the viral genome detection are different. The subset of breast cancer studied, using varied techniques like polymerase chain reaction (PCR), laser capture microdissection (LCM), IHC, ISH, and Southern Blot for EBV detection. Hence, it is the main reasons for the conflicting results. [26] [27] [28] Studies PCR as a highly sensitive and specific technique to detect EBV-DNA in breast cancer, leading to different results and making it difficult to determine whether EBV virus is correlated with breast cancer. In the present study, which was performed by PCR analysis, only 2 cases out of the 40 tumor samples (5%) were positive and none of 40 normal tissues, showed DNA-EBV, These results indicated that Epstein-Barr virus does not play a significant role in breast cancer in women from Khuzestan. In other studies, PCR and real-time PCR were used on 18 breast cancer tissues from Iran and EBV virus was not found. Hence, the EBV does not play a significant role in this disease in Iran. 29 The study by Morales-Sánchez et al using PCR technique to test whether EBV has such an association with breast cancer indicated that there is no significant relationship between EBV and Breast cancer. 30 Perrigoue et al applied RT-PCR and ISH on detecting the number of viral DNA molecules in normal and tumor biopsies from 45 cases and reported no significant association between EBV and breast cancer. 31 Eghbali et al tested a total of 24 carcinomas and 24 fibroadenomas paraffin embedded tumor tissue by PCR. They reported EBV infection in 16.6% of carcinoma and 4.1% of fibroadenoma samples, but this infection rate is statistically insignificant. 32 Kadivar et al assessed 100 breast cancer and normal samples by PCR and EBNA-1 and LMP-1 were not detected in all of them. 33 Different studies proposed the EBV virus may associate with breast cancer. 34, 35 They found material related to viruses in breast cancer. Herrmann and Niedobitek looked for EBV-DNA by PCR techniques, EBV encoded RNAs by in situ hybridization EBV and nuclear antigen by immunohistochemistry in 59 breast carcinoma biopsies. Only 4 out of 59 cases were positive for EBV-DNA, and other techniques ruled out the involvement of Epstein-Barr virus in the pathogenesis of breast carcinomas. 36 Tsai and colleagues used PCR and Southern hybridization to detect six viruses in breast cancer tissues, and it was seen that human herpesvirus (HHV)-8 and EBV were associated with this cancer. 37 In a study by Chu et al EBV-DNA detection was investigated by PCR using 48 samples of invasive breast cancer tissues, immunohistochemistry and in situ hybridization techniques and reported no significant correlation between this cancer and Epstein-Barr virus. 38 Mazouni et al by using RT-PCR in 196 breast cancer specimens showed the presence of EBV in 65 out of 196 breast cancer. 15 While some studies have shown that EBV may be present in breast cancer. Kazemi Aghdam et al studied 75 women with breast cancer and 75 cases with normal breast tissue by qualitative real-time PCR and 9.3% of tumor and 0% of normal tissues, the EBV-DNA was found. They suggested that EBV may have an etiologic role in breast cancer in Iran. 39 Joshi et al applied Immunohistochemistry and commercial enzyme-linked Immunosorbent assay (ELISA) kit and showed EBNA-1 expression in a significant proportion of breast cancer tissues from rural India. These patients also have a higher immunological response against EBNA-1 33. Although Joshi et al in their review article did not defend that EBV has an etiologic role in breast cancer. 12 Glenn et al conducted a study based on in situ PCR on 27 breast cancer specimens and 18 normal breast specimens from women who had breast reduction surgery. They detected that EBV sequences are present in many human breast cancers. 40 Richardson et al by QPCR and determination of serum immunoglobulin level for EBV and CMV, showed a possible association between EBV and breast cancer. They according to other PCR studies on EBV and CMV and breast cancer proposed several possibilities: 1, molecular analysis has limitations and cannot confirm whether the viruses are associated with breast cancer; however, using ISH in addition to PCR may increase the sensitivity; 2, the virus may be absent after development of the tumor, causing inconsistent results; 3, more viruses may be responsible for breast cancer development at a later stage; 4, multiple virus infections may increase the occurrence of breast cancer; 5, none of CMV and EBV has a role in cancer development. 41 Viruses such as HPV, HBV, and EBV cause genome instability and making the cell proliferation out of control. These can express oncogenes lead to inhibition of apoptosis and increase of cell immortalization. [42] [43] [44] Finally, to establish whether a virus is linked to cancer, some effective vaccines and antivirals can be used. If eliminating virus infection and cancer happened, or vaccines even change the age-old pattern of cancer, we can say there is a correlation between virus and cancer. But, the problem is that the specific drug and vaccine just exist for a virus that established to cause a disease or cancer. 45 
Conclusions
Our results showed that there is no etiologic relationship between Epstein-Barr virus and breast cancer in the women examined in Khuzestan province, or at least, EBV is not a major cause of breast cancer in woman from this province. Further investigation on more patients and in other regions are needed to demonstrate the association of EBV infection with breast cancer.
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